Summary
Urbanization is on the rise, with the UN predicting significant growth in cities over the coming decades. The challenge lies in ensuring these cities evolve intelligently to meet changing infrastructure demands. Dubai is highlighted as a model for smart city development, having successfully managed a population surge of one-third in just five years, thanks to its proactive urban planning and long-term vision.
In the financial sector, Alphabet faces scrutiny after disappointing earnings, particularly in its search and advertising business, which has seen the slowest growth in five quarters. This downturn raises concerns about the sustainability of its AI investments, especially as the company struggles to monetize its AI search features effectively. Meanwhile, Caterpillar's modest earnings report leads to a decline in its shares, reflecting investor impatience with companies in the AI infrastructure space.
On a more positive note, Eli Lilly reports strong performance, raising its sales guidance due to high demand for its obesity and diabetes medications. The company is expanding its product offerings, although it faces competition from Nova Nordisk in the weight loss market. Overall, the earnings season reveals a complex landscape for tech and healthcare companies as they navigate high expectations and evolving market dynamics.
Show Notes
On this episode of Stock Movers:
- Alphabet (GOOGL) shares fell more than 13% after the company reported disappointing search and advertising sales. The Google parent reported sales of $111.2 billion for the third quarter, falling short of analysts' projections, with ad sales from search and other channels growing at the slowest pace in five quarters. The company's future commitments to buy resources such as computing power and energy totaled $924 billion, with upcoming obligations bringing the company's total future obligations to well over $1 trillion.
- Caterpillar (CAT) shares plunged after the company posted earnings that only modestly beat expectations, adding to investor jitters about mounting challenges to the AI infrastructure boom. The company reported adjusted earnings of $7.20 a share in the third quarter, and overall revenue was $20.68 billion, just above the $20.65 billion consensus.
- Eli Lilly (LLY) shares rise. Eli Lilly & Co. raised its full-year sales forecast to $91 billion to $92 billion as demand for its obesity and diabetes drugs continues to surge. The company's shares jumped 8.6% when markets opened in New York on Thursday, with its booming obesity business transforming it into the world's most valuable drug company. Lilly is counting on broader insurance coverage to bring its obesity drugs to more patients, with about 500,000 Medicare patients accessing its obesity medicines through the Bridge program. See omnystudio.com/listener for privacy information.
More from Stock Movers
On this episode of Stock Movers:
Today's biggest winners and losers in the stock market. On this episode of Stock Movers: - Eli Lilly (LLY) is climbing in early trading after the drugmaker boosted its revenue guidance for the full year, following better-than-expected sales in the third quarter. - EBay (EBAY) shares jumped after the online auction company’s results and forecast were seen as underlining its strong execution and growth prospects. Wells Fargo upgraded the stock. - Caterpillar (CAT) shares are moving after it posted quarterly earnings that beat Wall Street expectations as demand for the company's power-generation equipment continued to drive sales. The company's power and energy segment has grown into its largest business by sales, driven by technology companies' need for infrastructure to meet AI's enormous electricity demand. See omnystudio.com/listener for privacy information.
Today's biggest winners and losers in the stock market. On this episode of Stock Movers: - Merck (MRK) shares are moving after it raised its full-year profit forecast after third-quarter results topped Wall Street’s expectations, fueled by stronger-than-anticipated sales of cancer blockbuster Keytruda and other newer medicines. The company boosted the lower end of its full-year sales forecast by $500 million and now expects adjusted earnings for the year of $2.77 to $2.82 a share. Sales of Keytruda in both its formulations combined were $8.6 billion, and the company is also developing a growing pipeline of experimental drugs, including a personalized skin cancer vaccine and sacituzumab tirumotecan. - Caterpillar (CAT) shares are moving after it posted quarterly earnings that beat Wall Street expectations as demand for the company's power-generation equipment continued to drive sales. The company's power and energy segment has grown into its largest business by sales, driven by technology companies' need for infrastructure to meet AI's enormous electricity demand. - Microsoft (MSFT) is higher this morning while Google-parent Alphabet (GOOG) is lower after reporting earnings yesterday. Microsoft gained after the software company’s first-quarter results beat expectations on key metrics, including growth in its Azure cloud-computing business. Alphabet, meanwhile, dropped after the Google parent’s third-quarter results featured weaker-than-expected revenue for both Google advertising and search, which offset strong growth in its cloud business. Analysts said the report adds to concerns about AI disrupting search and related businesses. - Marvell Technology (MRVL) shares are moving on news the company is in advanced talks to buy Lumentum, a data center optics maker, according to people familiar with the matter. A transaction may be announced as soon as next week, with Lumentum having a market value of about $83 billion and Marvell worth around $221 billion. See omnystudio.com/listener for privacy information.
Today's biggest winners and losers in the stock market. On this episode of Stock Movers: - Lloyds Banking Group Plc’s profit beat estimates in the third quarter, but disappointed investors as the UK lender kept its guidance steady against a rising rate environment. - Haleon shares fall as much as 14%, the most since its London listing in 2022, after the healthcare products provider cut its organic sales growth forecast. Analysts said the company flagged challenges in China and Brazil. - Shell shares gain as much as 3.5% after the oil major reported 3Q profit that beat analyst estimates and announced a $5b share buyback. Analysts at RBC see potential for a dividend increase. See omnystudio.com/listener for privacy information.
Today's biggest winners and losers in the stock market. On this episode of Stock Movers: - Samsung Electronics plans to hike spending more than 60% this year after selling out of high-end chips for 2027, yet its stock fell after the company failed to outline plans to share ballooning profits and tech shares slumped across Asia. - Shares in PetroChina are rising as investors are being rewarded for taking cover in state-owned enterprises. - Banks across APAC are rallying after Federal Reserve officials left interest rates unchanged yesterday. See omnystudio.com/listener for privacy information.